Application
Respiratory Infections
Respiratory tract infections are among the most common disorders affecting today’s population, representing the third cause of death in the whole world.

Product
LBM® Broth
Along with microbiology collection, preservation and transport systems, Copan’s portfolio includes a full range of enrichment and selective broths.

Brochure
LBM® Broth

Technology
Liquid-Based Microbiology™

Scientific study
Evidence of Common Isolates of Streptococcus agalactiae in Bovines and Humans in Emilia Romagna Region (Northern Italy)
Elena Carra et al.
Copan White Paper
Antibiotic resistance rise in Salmonella spp. and Campylobacter spp.
Matteo Miriani, Ph.D.
Fair
Asia Pacific Congress of Clinical Microbiology and Infection – APCCMI
APCCMI 2021 will build on this rich history in Singapore and regional collaboration. The congress will focus on:
- COVID-19
- Advances in infection control, microbiome and vaccines; new antimicrobials and antimicrobial stewardship.
- Advances in microbiology including rapid diagnostics, applications in whole-genome sequencing, laboratory automation;
- Antimicrobial resistance in humans and within the One Health context of animals, humans and the environment;
- Challenges and progress in the three pandemic infections of HIV, Malaria, and Tuberculosis;
- Emerging infectious diseases prevalent in the region (Chikungunya, Dengue, Zika) and globally (Avian and seasonal influenza, MERS-CoV)
Fair
Asia Pacific Congress of Clinical Microbiology and Infection – APCCMI
The primary goal of the APCCMI international conference is to broaden medical knowledge while strengthening personal and professional networks. This year, the meeting will return to the in-person format, bringing clinical microbiologists, infectious disease physicians, infection control professionals, and public health scientists from Asia Pacific countries together to share their expertise, remarkable achievements, and innovative ideas through active intellectual collaboration. The scientific program will reflect the changing landscape of clinical microbiology and infection through the pandemic of COVID-19 and AMR.